*For scientific and strategic considerations, we are developing two distinct lead molecules in parallel. AID: autoimmune diseases; PH: primary hyperoxaluria (rare disease).
Primary hyperoxaluria (PH) is a group of rare inherited metabolic disorders that lead to oxalate overproduction, causing recurrent kidney stones and renal damage over time. The disease typically presents in childhood or adolescence, though some patients are not diagnosed until adulthood.
In response to unmet needs, META is steadily advancing the META-001-PH program, striving to bring more possibilities and opportunities for the treatment of this disease.
